The guidelines recommend less stringent targets in patients who are unable to communicate their symptoms or who have hypoglycemia unawareness, recurrent severe hypoglycemia, lack of access to insulin analogs and advanced insulin delivery technology, or inability to regularly monitor BG levels (6, 7, 82). Here, INS is linked to Hypoglycemia.